Products
Our portfolio of innovative therapies is designed to meet the unique needs of several underserved patient populations.
|
Carbaglu® (carglumic acid dispersible tablets) |
Product Monograph | Consumer Information |
|
Cosmegen® (dactinomycin for injection) |
Product Monograph | Consumer Information |
|
Cystadane® (betaine anhydrous powder for oral solution) |
Product Monograph | Consumer Information |
| Cystadrops® (cysteamine ophthalmic solution) | Product Monograph | Consumer Information |
| Panhematin® (hemin for injection) | Product Monograph | Consumer Information |
| Signifor® LAR (pasireotide for injectable suspension) | Product Monograph | Consumer Information |
| Signifor® (pasireotide injection) | Product Monograph | Consumer Information |
| Ledaga™ (chlormethine gel) | Product Monograph | Consumer Information |
| SYLVANT® (siltuximab for injection) | Product Monograph | Consumer Information |
Support & Resources
Our top priority is meeting the needs of the rare disease community.
Contact us
Contact Recordati Rare Diseases Canada.